| c(phg-isoDGR-(NMe)k) |
C(PHG-ISODGR-(NME)K) |
1844830-65-4 |
| Vipivotide tetraxetan Linker |
Vipivotide tetraxetan Linker |
1703768-74-4 |
| PSMA-617 |
1702967-37-0 |
1702967-37-0 |
| PD-1-IN-17 |
PD-1-IN-17 |
1673560-66-1 |
| YAP-TEAD Inhibitor 1 |
YAP-TEAD Inhibitor 1 |
1659305-78-8 |
| SAH-SOS1A |
SAH-SOS1A |
1652561-87-9 |
| Fmoc-Phe-Lys(Boc)-PAB-PNP |
FMOC-PHE-LYS(BOC)-PAB-PNP |
1646299-50-4 |
| Myostatin inhibitory peptide 7 |
肌抑素抑制肽7 |
1621169-52-5 |
| (D)-PPA 1 |
H-D-ASN-D-TYR-D-SER-D-LYS-D-PRO-D-THR-D-ASP-D-ARG-D-GLN-D-TYR-D-HIS-D-PHE-OH |
1620813-53-7 |
| 7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
4,9-二氧代-11-苯基-7,10-二氧杂-2,5-二氮杂十一烷酸(9H-芴-9-基)甲酯 |
1599440-07-9 |
| Octreotide Impurity |
奥曲肽杂质 |
1546983-33-8 |
| TAT-Gap19 |
TAT-Gap19 |
1507930-54-2 |
| mDPR-Val-Cit-PAB-MMAE |
1491152-26-1 |
1491152-26-1 |
| Vosoritide acetate |
伏索利肽 |
1480724-61-5 |
| SAH-EZH2 |
SAH-EZH2 |
1453222-26-8 |
| RS 09 |
H-ALA-PRO-PRO-HIS-ALA-LEU-SER-OH |
1449566-36-2 |
| TAT-cyclo-CLLFVY |
TAT-cyclo-CLLFVY |
1446322-66-2 |
| ciraparantag,Aripazine,PER977 |
(2S,2'S)-N,N'-(1,4-哌嗪二基二-3,1-丙烷二基)二[2-氨基-5-[(氨基亚胺甲基)氨基]戊酰胺] |
1438492-26-2 |
| NoxA1ds |
H-GLU-PRO-VAL-ASP-ALA-LEU-GLY-LYS-ALA-LYS-VAL-NH2 |
1435893-78-9 |
| Compstatin analog peptide CP40 |
Compstatin analog peptide CP40 |
1427001-89-5 |
QQ
微信
